Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic updates on $43B Covidien deal financing; Boston Scientific, Bard CEOs cool on consolidation; Nevro sets range for IPO of up to $106m; Alere to sell Alere Health unit to Optum for $600m; Skyline Medical conducts 1-for-75 reverse stock split
Medtronic updates on $43B Covidien deal financing
October 24, 2014 by Brad Perriello
Boston Scientific, C.R. Bard, Covidien, Medtronic, Nevro Corp., Optum, Skyline Medical, Standard & Poor's, Alere
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tTQob6
Cap comentari:
Publica un comentari a l'entrada